Mar 13, 2025 · Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery and development of proprietary drugs for the treatment of cancer, independently and through research and development collaborations.

Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital information to help you with your stock trading and investing.

Apr 9, 2025 · Cellectar Biosciences, Inc. (NasdaqCM:CLRB) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or …

Apr 8, 2025 · CLRB | Complete Cellectar Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer.

A pivotal project for Cellectar is CLR 131, an investigational radioiodinated therapeutic that targets malignant tumor cells in select hematologic malignancies, including multiple myeloma and other niche cancer types at various stages.

Apr 10, 2025 · Explore Cellectar Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLRB.

Pareb- Calamba Laguna Real Estate Board, Inc. 311 likes · 2 talking about this. CLRB is one of the local board of the Philippine Association of Real...

Cellectar Biosciences Inc. analyst estimates, including CLRB earnings per share estimates and analyst recommendations.

Jan 25, 2025 · Calamba-Laguna Real Estate Board, Inc. (CLRB) is your gateway to a thriving real estate career. Our organization offers a wide range of invaluable resources and services tailored to both new and experienced real estate practitioners. For those new to the industry, CLRB provides mentorship programs to guide you on your journey.